At a glance
- Originator PharmaMar
- Class Antivirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 11 Oct 1999 Discontinued-Preclinical for HIV-1 infections in Spain (Unknown route)
- 21 Jul 1998 No-Development-Reported for HIV-1 infections in Spain (Unknown route)
- 21 Sep 1995 New profile